GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Gross Margin %

RP Bio lnc (XKRX:314140) Gross Margin % : 5.97% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. RP Bio lnc's Gross Profit for the three months ended in Dec. 2023 was ₩2,125 Mil. RP Bio lnc's Revenue for the three months ended in Dec. 2023 was ₩35,572 Mil. Therefore, RP Bio lnc's Gross Margin % for the quarter that ended in Dec. 2023 was 5.97%.


The historical rank and industry rank for RP Bio lnc's Gross Margin % or its related term are showing as below:

XKRX:314140' s Gross Margin % Range Over the Past 10 Years
Min: 10.31   Med: 12.89   Max: 15.43
Current: 10.31


During the past 4 years, the highest Gross Margin % of RP Bio lnc was 15.43%. The lowest was 10.31%. And the median was 12.89%.

XKRX:314140's Gross Margin % is ranked worse than
92.53% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.5 vs XKRX:314140: 10.31

RP Bio lnc had a gross margin of 5.97% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for RP Bio lnc was 0.00% per year.


RP Bio lnc Gross Margin % Historical Data

The historical data trend for RP Bio lnc's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Gross Margin % Chart

RP Bio lnc Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Gross Margin %
15.43 12.91 11.25 12.87

RP Bio lnc Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.97 7.34 13.65 13.46 5.97

Competitive Comparison of RP Bio lnc's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RP Bio lnc's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's Gross Margin % distribution charts can be found below:

* The bar in red indicates where RP Bio lnc's Gross Margin % falls into.



RP Bio lnc Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

RP Bio lnc's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=17779.3 / 138109.319
=(Revenue - Cost of Goods Sold) / Revenue
=(138109.319 - 120330.016) / 138109.319
=12.87 %

RP Bio lnc's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=2124.6 / 35571.748
=(Revenue - Cost of Goods Sold) / Revenue
=(35571.748 - 33447.185) / 35571.748
=5.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


RP Bio lnc  (XKRX:314140) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

RP Bio lnc had a gross margin of 5.97% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


RP Bio lnc Gross Margin % Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


RP Bio lnc (XKRX:314140) Business Description

Traded in Other Exchanges
N/A
Address
634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084
RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines